Sakai F, Suzuki N, Kim BK, Tatsuoka Y, et al. Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients. Headache 2021 Jul 29. doi: 10.1111/head.14178.
PMID: 34323290